J.D. Vance: Wall Street Will Tank Bonds to Sabotage Trump

J.D. Vance just dropped a bombshell: With Trump in office, Wall Street could drive the bond market into a death spiral—and your savings might be the first to get crushed.

Martha Marsh Biography and Net Worth

Director of Edwards Lifesciences

Martha H. Marsh serves as Lead Independent Director of the Company. Ms. Marsh’s experience of more than 30 years in an increasingly complex and evolving healthcare system as a president and chief executive officer, combined with years of board experience that includes corporate governance chairmanships, provide a unique perspective as our Board considers the execution of our patient-focused innovation strategy.

What is Martha H. Marsh's net worth?: The estimated net worth of Martha H. Marsh is at least $1.81 million as of April 28th, 2022. Ms. Marsh owns 26,777 shares of Edwards Lifesciences stock worth more than $1,814,410 as of November 18th. This net worth approximation does not reflect any other investments that Ms. Marsh may own. Learn More about Martha H. Marsh's net worth.
How do I contact Martha H. Marsh?: The corporate mailing address for Ms. Marsh and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Martha H. Marsh's contact information.
Has Martha H. Marsh been buying or selling shares of Edwards Lifesciences?: Martha H. Marsh has not been actively trading shares of Edwards Lifesciences in the last ninety days. Most recently, Martha H. Marsh sold 28,722 shares of the business's stock in a transaction on Thursday, April 28th. The shares were sold at an average price of $108.09, for a transaction totalling $3,104,560.98. Following the completion of the sale, the director now directly owns 26,777 shares of the company's stock, valued at $2,894,325.93. Learn More on Martha H. Marsh's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 38 times. They sold a total of 431,721 shares worth more than $35,433,938.52. The most recent insider tranaction occured on November, 13th when VP Donald E Bobo Jr sold 5,000 shares worth more than $327,850.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 11/13/2024.

Martha H. Marsh Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/28/2022	Sell	28,722	$108.09	$3,104,560.98	26,777

Martha H. Marsh Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $67.76

$67.76

50 Day Range

MA: $67.44

$64.54

$70.63

2 Week Range

Now: $67.76

$58.93

$96.12

Volume

2,509 shs

Average Volume

4,622,595 shs

Market Capitalization

$39.96 billion

P/E Ratio

9.78

Dividend Yield

N/A

Beta

1.12

J.D. Vance: Wall Street Will Tank Bonds to Sabotage Trump

From Golden Crest | Ad